VVM
Versant Venture Management Portfolio holdings
AUM
$82.1M
This Quarter Return
+0.13%
1 Year Return
-26.22%
3 Year Return
+73.87%
5 Year Return
-1.11%
10 Year Return
+1,578.11%
AUM
$86.7M
AUM Growth
+$86.7M
(+36%)
Cap. Flow
+$40.1M
Cap. Flow
% of AUM
46.22%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
2
Increased
–
Reduced
–
Closed
1
Top Buys
| 1 |
Monte Rosa Therapeutics
GLUE
|
$39.2M |
| 2 |
Tempest Therapeutics
TPST
|
$2.93M |
Top Sells
| 1 |
GRTS
Gritstone bio, Inc. Common Stock
GRTS
|
$2.07M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Monte Rosa Therapeutics
GLUE
$296M
| $39.2M | 45.22% | +5,652,922 | New | +$39.2M |
|
2
CRISPR Therapeutics
CRSP
$4.71B
| $19.6M | 22.62% | 498,558 | – | – |
|
|
CTNM
3
Contineum Therapeutics
CTNM
$293M
| $13.5M | 15.51% | 918,163 | – | – |
|
4
Skye Bioscience
SKYE
$108M
| $5.68M | 6.55% | 2,007,704 | – | – |
|
5
Repare Therapeutics
RPTX
$71.7M
| $3.47M | 4% | 2,646,657 | – | – |
|
|
6
Tempest Therapeutics
TPST
$44M
| $2.93M | 3.37% | +3,507,055 | New | +$2.93M |
|
7
Adverum Biotechnologies
ADVM
$64.6M
| $2.37M | 2.73% | 506,821 | – | – |
|
|
GRTS
8
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| – | – | -3,561,150 | Closed | -$2.07M |
|